Val C. Sheffield
About
In The Last Decade
Val C. Sheffield
308 papers receiving 27.0k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Molecular Biology 17.1k
- Genetics 10.4k
- Ophthalmology 6.6k
- Cell Biology 3.8k
- Radiology, Nuclear Medicine and Imaging 2.5k
Countries citing papers authored by Val C. Sheffield
This map shows the geographic impact of Val C. Sheffield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Val C. Sheffield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Val C. Sheffield more than expected).
Fields of papers citing papers by Val C. Sheffield
This network shows the impact of papers produced by Val C. Sheffield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Val C. Sheffield. The network helps show where Val C. Sheffield may publish in the future.
Co-authorship network of co-authors of Val C. Sheffield
This figure shows the co-authorship network connecting the top 25 collaborators of Val C. Sheffield. A scholar is included among the top collaborators of Val C. Sheffield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Val C. Sheffield. Val C. Sheffield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 38 | |
| 3 | 8 | |
| 4 | 62 | |
| 5 | Retinal degeneration in BBS10 mice is ameliorated by subretinal gene replacement | 1 |
| 6 | Genetic and pharmacological inhibition of ER stress-induced ATF4/CHOP pro-death pathway prevents myocilin misfolding and rescues mouse models of glaucoma | 1 |
| 7 | Elevation of IOP triggers responses from cytokines IL-6 and IL-1β; involvement of both optic nerve head astrocytes and retinal ganglion cells | 3 |
| 8 | 28 | |
| 9 | 159 | |
| 10 | 239 | |
| 11 | 193 | |
| 12 | 268 | |
| 13 | Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. | 59 |
| 14 | Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. | 131 |
| 15 | Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. | 98 |
| 16 | Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization. | 80 |
| 17 | Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. | 126 |
| 18 | Predictive DNA testing for glaucoma with the GLC1A gene: experience with a large Australian family | 1 |
| 19 | Photoreceptor function in patients with heterozygous peripherin/RDS gene mutations | 3 |
| 20 | Medical genetics: An illustrated outline | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.